← Companies|Processa Pharma
PC

Processa Pharma

PCSA·NASDAQHanover MDFounded 20158 employees
Micro CapbiotechPublicOncology
Platform: Next-PharmaKin
Market Cap
$0.01B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PCSA)
Loading PCSA stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
PolatuximabPCS-8309Phase 1/22siRNATROP-2BCL-2iPancreatic CaThymoma
RilubrutinibPCS-6817Phase 12VaccineFcRnSTINGagCRC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2026-12-13
Polatuximab Orphan Drug
Thymoma
Orphan Drug
2028-03-25
Polatuximab Ph2 Data
Thymoma
Ph2 Data
2028-05-24
Polatuximab Ph2 Data
Pancreatic Ca
Ph2 Data
2029-02-17
Rilubrutinib Interim
CRC
Interim
2030-05-28
Rilubrutinib Interim
CRC
Interim